Suppr超能文献

相似文献

1
A Perspective on the Evolving Story of PSMA Biology, PSMA-Based Imaging, and Endoradiotherapeutic Strategies.
J Nucl Med. 2018 Jul;59(7):1007-1013. doi: 10.2967/jnumed.117.203877. Epub 2018 Apr 19.
2
Radiolabeled enzyme inhibitors and binding agents targeting PSMA: Effective theranostic tools for imaging and therapy of prostate cancer.
Nucl Med Biol. 2016 Nov;43(11):692-720. doi: 10.1016/j.nucmedbio.2016.08.006. Epub 2016 Aug 11.
3
Design of Internalizing PSMA-specific Glu-ureido-based Radiotherapeuticals.
Theranostics. 2016 Apr 28;6(8):1085-95. doi: 10.7150/thno.13448. eCollection 2016.
4
68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies.
J Nucl Med. 2015 Aug;56(8):1169-76. doi: 10.2967/jnumed.115.158550. Epub 2015 Jun 18.
5
Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer: An Update on Important Pitfalls.
Semin Nucl Med. 2019 Jul;49(4):255-270. doi: 10.1053/j.semnuclmed.2019.02.006. Epub 2019 Mar 4.
6
The Rise of PSMA Ligands for Diagnosis and Therapy of Prostate Cancer.
J Nucl Med. 2016 Oct;57(Suppl 3):79S-89S. doi: 10.2967/jnumed.115.170720.
9
Tumor target prostate specific membrane antigen (PSMA) and its regulation in prostate cancer.
J Cell Biochem. 2004 Feb 15;91(3):528-39. doi: 10.1002/jcb.10661.

引用本文的文献

1
Radionuclides Landscape in Prostate Cancer Theranostics.
Int J Mol Sci. 2025 Jul 14;26(14):6751. doi: 10.3390/ijms26146751.
5
Prostate-specific membrane antigen-targeting radiopharmaceuticals: a new frontier in hepatic malignancies.
Front Oncol. 2025 Mar 7;15:1547459. doi: 10.3389/fonc.2025.1547459. eCollection 2025.
8
Standardized template for clinical reporting of PSMA PET/CT scans.
Eur J Nucl Med Mol Imaging. 2024 Dec;52(1):335-341. doi: 10.1007/s00259-024-06857-w. Epub 2024 Aug 15.
9
Parathyroid Adenoma Detected in Ga-PSMA PET/CT but Not in the Dedicated Imaging Modalities.
Diagnostics (Basel). 2024 Aug 5;14(15):1690. doi: 10.3390/diagnostics14151690.
10
Diagnostic efficacy of [Tc]Tc-PSMA SPECT/CT for prostate cancer: a meta-analysis.
BMC Cancer. 2024 Aug 8;24(1):982. doi: 10.1186/s12885-024-12734-4.

本文引用的文献

1
Imaging of Nonprostate Cancers Using PSMA-Targeted Radiotracers: Rationale, Current State of the Field, and a Call to Arms.
J Nucl Med. 2018 Jun;59(6):871-877. doi: 10.2967/jnumed.117.203570. Epub 2018 Mar 15.
5
Prostate-Specific Membrane Antigen Ligands for Imaging and Therapy.
J Nucl Med. 2017 Sep;58(Suppl 2):67S-76S. doi: 10.2967/jnumed.116.186767.
7
Lu-PSMA Radioligand Therapy for Prostate Cancer.
J Nucl Med. 2017 Aug;58(8):1196-1200. doi: 10.2967/jnumed.117.191023. Epub 2017 Jun 29.
8
Acceleration of PSMA-Targeted Theranostics to the Clinic: Can Common Sense Prevail?
J Nucl Med. 2017 Aug;58(8):1186-1187. doi: 10.2967/jnumed.117.193516. Epub 2017 May 4.
9
Bi-PSMA-617 targeted alpha-radionuclide therapy in metastatic castration-resistant prostate cancer.
Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):1099-1100. doi: 10.1007/s00259-017-3657-9. Epub 2017 Mar 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验